What serum-ascites albumin gradient (SAAG) is indicative of cirrhosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Serum-Ascites Albumin Gradient (SAAG) in Cirrhosis

A SAAG >11g/L (or ≥1.1 g/dL) is consistent with the diagnosis of cirrhosis. 1

Understanding SAAG and Its Diagnostic Value

The serum-ascites albumin gradient (SAAG) is a valuable diagnostic tool that helps differentiate the causes of ascites. It is calculated by subtracting the ascitic fluid albumin concentration from the serum albumin concentration.

SAAG Classification:

  • High SAAG (≥1.1 g/dL or ≥11 g/L): Indicates portal hypertension, typically seen in:

    • Cirrhosis
    • Alcoholic hepatitis
    • Heart failure
    • Budd-Chiari syndrome
  • Low SAAG (<1.1 g/dL or <11 g/L): Indicates causes unrelated to portal hypertension:

    • Malignancy (peritoneal carcinomatosis)
    • Tuberculosis
    • Nephrotic syndrome
    • Pancreatic ascites

Evidence Supporting SAAG in Cirrhosis Diagnosis

Multiple studies have confirmed that SAAG is superior to the traditional exudate-transudate classification based on ascitic fluid total protein (AFTP) 2. The diagnostic accuracy of SAAG for portal hypertension-related ascites is remarkably high:

  • Sensitivity: 97%
  • Specificity: 95%
  • Positive predictive value: 98.6%
  • Negative predictive value: 90%
  • Overall diagnostic accuracy: 96% 1

In contrast, the traditional ascitic fluid total protein method has significantly lower diagnostic efficacy:

  • Sensitivity: 53%
  • Specificity: 70%
  • Diagnostic accuracy: 56% 1

Clinical Applications and Limitations

Strong Correlation with Portal Hypertension

SAAG correlates well with portal hypertension in cirrhotic patients. Studies have shown that 84.6% of patients with cirrhosis have a high SAAG (≥1.1 g/dL) 3.

Prediction of Esophageal Varices

A high SAAG is also useful in predicting the presence of esophageal varices in patients with ascites:

  • 91% of cirrhotic patients with high SAAG have esophageal varices
  • Only 50% of cirrhotic patients with low SAAG have esophageal varices 3

Limitations and Pitfalls

  • False low SAAG can occasionally occur in cirrhotic patients. In one study, 15.4% of patients with confirmed cirrhosis had a low SAAG 3.

  • When a low SAAG is found in a patient with known cirrhosis, consider:

    1. Spontaneous bacterial peritonitis
    2. Peritoneal carcinomatosis
    3. Nephrotic syndrome 4
    4. Laboratory error
  • A repeat paracentesis is recommended when a low SAAG is found in a patient with known cirrhosis, as 73% of such patients will show a high SAAG on repeat testing 4.

Conclusion

When evaluating ascites, SAAG provides critical diagnostic information about the underlying pathophysiology. A SAAG ≥1.1 g/dL (≥11 g/L) strongly supports portal hypertension as the cause of ascites, which is typically seen in cirrhosis. This makes option A (SAAG >11g) the correct answer for the diagnosis of cirrhosis.

References

Research

Role of serum-ascites albumin gradient in differential diagnosis of ascites.

Journal of Ayub Medical College, Abbottabad : JAMC, 2012

Research

[Sero-ascitic gradient of albumin: usefulness and diagnostic limitations].

Anales de medicina interna (Madrid, Spain : 1984), 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.